Spinal Dynamics Corp.

Spinal Dynamics Corp. hopes that its spinal disc replacement system will simulate the cushioning function of a normal disc, to restore a patient's normal movement and prevent the degeneration of adjacent discs.

Where hips and knees go, the spine will follow. Not only is this the case with human perambulation, but it is also the course which orthopedic devices are following. Earlier this century, a surgeon might have fused the joints of a person suffering severe knee pain from a degenerative condition. This went a long way towards alleviating pain but didn't do much to improve the patient's mobility. While the current standard of care for knee and hip ailments has reached the point where prosthetic joint replacements are routinely implanted to reduce pain and increase mobility, the spine's complexity has so far defied the design of a successful disc prosthesis and procedures requiring vertebral fusion are still the norm. Spinal Dynamics Corp. hopes that its spinal disc replacement system will simulate the cushioning function of a normal disc, to restore a patient's normal movement and prevent the degeneration of adjacent discs.

A major cause of spinal disorders, particularly in the cervical (neck) and lumbar (lower) spine, is degenerative disc disease. A...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep & FDA Rules

In this week's Digital Health Roundup, Medtech Insight's team discusses progress on autonomous surgery, Medtronic's new partnership with IRCAD, FDA cybersecurity news, and C-suite interviews with OpenWater, Flow Neuroscience and EnsoData.

Whoops! FDA Says Company Marketed Unauthorized Device. The Company Says The FDA Is Wrong

 

A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.

With CMS Coverage Established, Medtronic Looks To Next Steps For Renal Denervation

 
• By 

US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the